Both in Pharmaceuticals
Entrada Therapeutics vs CAMP4 Therapeutics
Over the past year TRDA returned +7.2% and CAMP returned +27.4%; their daily moves had a correlation of 0.04.
TRDA +7.2% CAMP +27.4%Growth of $1, one year, split-adjusted
| Metric | TRDA | CAMP |
|---|---|---|
| Price | $6.26 | $3.91 |
| Market cap | $243.7M | $245.4M |
| Today | +0.64% | +1.56% |
| 1 month | −10.6% | −5.8% |
| 6 months | −46.8% | −2.3% |
| Year to date | −39.1% | −36.2% |
| 1 year | +7.9% | +31.2% |
| Revenue growth (YoY) | −53.9% | +18.8% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −4762.0% | −1884.8% |
| P/E (TTM) | — | — |
| Price / sales | 52.0× | 58.2× |
| Net cash | $223.0M | $86.4M |
| Dividend yield | — | — |
| Volatility (60d) | 64.6% | 97.1% |
| Short % of float | 11.5% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).